发明名称 VIRAL DEFEKT VAKSINE PRODUSERT AV TRANSKOMPLEMENTERENDE CELLELINJE
摘要 <p>A mutant virus for use as a vaccine, wherein the genome of the virus is defective in respect of a gene essential for the production of infectious virus. In one aspect the mutant virus is capable of protecting a susceptible species immunized therewith against infection by the corresponding wild-type virus. In another aspect, the mutant virus acts as a vector for an immunogenic protein derived from a pathogen and which is encoded by foreign DNA incorporated in the mutant virus. The mutant virus can be produced in a recombinant host cell which expresses a gene complementing the defect. The mutant virus is preferably infectious for the host to be protected, but the defective gene allows expression in the infected host of at least some of the viral genes, which can provoke a cell-mediated immune response.</p>
申请公布号 NO931057(A) 申请公布日期 1993.05.03
申请号 NO19930001057 申请日期 1993.03.23
申请人 CANTAB PHARMACEUTICALS RESEARCH LIMITED 发明人 INGLIS, STEPHEN CHARLES;BOURSNELL, MICHAEL EDWARD GRIFFITH;MINSON, ANTHONY CHARLES
分类号 A61K39/00;A61K39/21;A61K39/245;A61P31/12;A61P31/22;C07K14/155;C12N7/00;C12N7/01;C12N15/09;C12N15/869;(IPC1-7):C12N7/04;A61K39/12;A61K35/76 主分类号 A61K39/00
代理机构 代理人
主权项
地址